On the other hand, in an experimental study on rats by Debelle et al. [16], pharmacological RAS blockade with the combination of an ACE inhibitor and an AT1R antagonist failed to improve renal function in AAI-induced nephropathy. The gene discussed is AGTR1; the disease is kidney disorder.